US FDA Wants Advice About Advisory Committees: Try Having Some?

 
• By Michael McCaughan
  
conference room
The focus on adcomm perception does not make much sense given that CDER is having so few meetings, McCaughan argues. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US FDA Performance Tracker

More from Regulatory Trackers